Nanolive’s technology de-risks the biopharma investments into in-vivo studies by providing a game changing label-free new access to living cells. Our data rich analysis offers new scientific insights that would be missed with simple endpoint or fluorescence-based assays. A revolutionary non-invasive live cell imaging platform for drug discovery and research.
De-risk in-vivo studies with Nanolive label-free high content phenotypic solutions
From cell populations, to organelles
Nanolive imaging is unique in that it allows to image and analyze cells at the population level without compromising the organellular resolution we are renowned for, all for long periods of time (up to weeks), without damage.